G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.

<h4>Background</h4>Primaquine is a key drug for malaria elimination. In addition to being the only drug active against the dormant relapsing forms of Plasmodium vivax, primaquine is the sole effective treatment of infectious P. falciparum gametocytes, and may interrupt transmission and h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosalind E Howes, Frédéric B Piel, Anand P Patil, Oscar A Nyangiri, Peter W Gething, Mewahyu Dewi, Mariana M Hogg, Katherine E Battle, Carmencita D Padilla, J Kevin Baird, Simon I Hay
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Acceso en línea:https://doaj.org/article/c98992c83995453487fb935a69afe852
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c98992c83995453487fb935a69afe852
record_format dspace
spelling oai:doaj.org-article:c98992c83995453487fb935a69afe8522021-11-18T05:42:49ZG6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.1549-12771549-167610.1371/journal.pmed.1001339https://doaj.org/article/c98992c83995453487fb935a69afe8522012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23152723/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Primaquine is a key drug for malaria elimination. In addition to being the only drug active against the dormant relapsing forms of Plasmodium vivax, primaquine is the sole effective treatment of infectious P. falciparum gametocytes, and may interrupt transmission and help contain the spread of artemisinin resistance. However, primaquine can trigger haemolysis in patients with a deficiency in glucose-6-phosphate dehydrogenase (G6PDd). Poor information is available about the distribution of individuals at risk of primaquine-induced haemolysis. We present a continuous evidence-based prevalence map of G6PDd and estimates of affected populations, together with a national index of relative haemolytic risk.<h4>Methods and findings</h4>Representative community surveys of phenotypic G6PDd prevalence were identified for 1,734 spatially unique sites. These surveys formed the evidence-base for a Bayesian geostatistical model adapted to the gene's X-linked inheritance, which predicted a G6PDd allele frequency map across malaria endemic countries (MECs) and generated population-weighted estimates of affected populations. Highest median prevalence (peaking at 32.5%) was predicted across sub-Saharan Africa and the Arabian Peninsula. Although G6PDd prevalence was generally lower across central and southeast Asia, rarely exceeding 20%, the majority of G6PDd individuals (67.5% median estimate) were from Asian countries. We estimated a G6PDd allele frequency of 8.0% (interquartile range: 7.4-8.8) across MECs, and 5.3% (4.4-6.7) within malaria-eliminating countries. The reliability of the map is contingent on the underlying data informing the model; population heterogeneity can only be represented by the available surveys, and important weaknesses exist in the map across data-sparse regions. Uncertainty metrics are used to quantify some aspects of these limitations in the map. Finally, we assembled a database of G6PDd variant occurrences to inform a national-level index of relative G6PDd haemolytic risk. Asian countries, where variants were most severe, had the highest relative risks from G6PDd.<h4>Conclusions</h4>G6PDd is widespread and spatially heterogeneous across most MECs where primaquine would be valuable for malaria control and elimination. The maps and population estimates presented here reflect potential risk of primaquine-associated harm. In the absence of non-toxic alternatives to primaquine, these results represent additional evidence to help inform safe use of this valuable, yet dangerous, component of the malaria-elimination toolkit. Please see later in the article for the Editors' Summary.Rosalind E HowesFrédéric B PielAnand P PatilOscar A NyangiriPeter W GethingMewahyu DewiMariana M HoggKatherine E BattleCarmencita D PadillaJ Kevin BairdSimon I HayPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 9, Iss 11, p e1001339 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Rosalind E Howes
Frédéric B Piel
Anand P Patil
Oscar A Nyangiri
Peter W Gething
Mewahyu Dewi
Mariana M Hogg
Katherine E Battle
Carmencita D Padilla
J Kevin Baird
Simon I Hay
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
description <h4>Background</h4>Primaquine is a key drug for malaria elimination. In addition to being the only drug active against the dormant relapsing forms of Plasmodium vivax, primaquine is the sole effective treatment of infectious P. falciparum gametocytes, and may interrupt transmission and help contain the spread of artemisinin resistance. However, primaquine can trigger haemolysis in patients with a deficiency in glucose-6-phosphate dehydrogenase (G6PDd). Poor information is available about the distribution of individuals at risk of primaquine-induced haemolysis. We present a continuous evidence-based prevalence map of G6PDd and estimates of affected populations, together with a national index of relative haemolytic risk.<h4>Methods and findings</h4>Representative community surveys of phenotypic G6PDd prevalence were identified for 1,734 spatially unique sites. These surveys formed the evidence-base for a Bayesian geostatistical model adapted to the gene's X-linked inheritance, which predicted a G6PDd allele frequency map across malaria endemic countries (MECs) and generated population-weighted estimates of affected populations. Highest median prevalence (peaking at 32.5%) was predicted across sub-Saharan Africa and the Arabian Peninsula. Although G6PDd prevalence was generally lower across central and southeast Asia, rarely exceeding 20%, the majority of G6PDd individuals (67.5% median estimate) were from Asian countries. We estimated a G6PDd allele frequency of 8.0% (interquartile range: 7.4-8.8) across MECs, and 5.3% (4.4-6.7) within malaria-eliminating countries. The reliability of the map is contingent on the underlying data informing the model; population heterogeneity can only be represented by the available surveys, and important weaknesses exist in the map across data-sparse regions. Uncertainty metrics are used to quantify some aspects of these limitations in the map. Finally, we assembled a database of G6PDd variant occurrences to inform a national-level index of relative G6PDd haemolytic risk. Asian countries, where variants were most severe, had the highest relative risks from G6PDd.<h4>Conclusions</h4>G6PDd is widespread and spatially heterogeneous across most MECs where primaquine would be valuable for malaria control and elimination. The maps and population estimates presented here reflect potential risk of primaquine-associated harm. In the absence of non-toxic alternatives to primaquine, these results represent additional evidence to help inform safe use of this valuable, yet dangerous, component of the malaria-elimination toolkit. Please see later in the article for the Editors' Summary.
format article
author Rosalind E Howes
Frédéric B Piel
Anand P Patil
Oscar A Nyangiri
Peter W Gething
Mewahyu Dewi
Mariana M Hogg
Katherine E Battle
Carmencita D Padilla
J Kevin Baird
Simon I Hay
author_facet Rosalind E Howes
Frédéric B Piel
Anand P Patil
Oscar A Nyangiri
Peter W Gething
Mewahyu Dewi
Mariana M Hogg
Katherine E Battle
Carmencita D Padilla
J Kevin Baird
Simon I Hay
author_sort Rosalind E Howes
title G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
title_short G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
title_full G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
title_fullStr G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
title_full_unstemmed G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
title_sort g6pd deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/c98992c83995453487fb935a69afe852
work_keys_str_mv AT rosalindehowes g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT fredericbpiel g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT anandppatil g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT oscaranyangiri g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT peterwgething g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT mewahyudewi g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT marianamhogg g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT katherineebattle g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT carmencitadpadilla g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT jkevinbaird g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
AT simonihay g6pddeficiencyprevalenceandestimatesofaffectedpopulationsinmalariaendemiccountriesageostatisticalmodelbasedmap
_version_ 1718424815209021440